P&G Health Q3: Rs 160 Interim Dividend Declared, Includes Rs 50 One-Time Special

Revenue Growth 20pctResults View source PDF Explain this filing

PGHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹5235.00

prior close

₹5189.00

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.8%-0.3% vs market

Pharmaceuticals peers, median of 159sector-0.6%-0.5% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1-0.8-0.3-0.6-0.5

Next day

+2.8+1.8+1.0+1.1+1.6

+5.3+2.8+2.5+1.7+3.6

+4.7+2.3+2.4+1.3+3.4

-1.1+1.8-2.8+0.7-1.7

-3.9+0.3-4.2+0.0-4.0

-2.9+0.5-3.4-0.2-2.7

15d

-5.9-2.5-3.4-2.3-3.6

-6.7-6.3-0.4-4.4-2.4

-8.2-8.0-0.3-7.2-1.0

+2.2+8.3-6.0+2.7-0.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

P&G Health reported Q3 FY26 revenue of Rs 373.86 crore, up 20.7 percent YoY from Rs 309.77 crore. Net profit was Rs 77.59 crore versus Rs 90.90 crore, a 14.6 percent decline. For 9M FY26, revenue rose 14.4 percent to Rs 1,037.52 crore and PAT grew 22.3 percent to Rs 232.31 crore. Board declared Rs 160 interim dividend per share including Rs 50 one-time special dividend. Record date February 12, 2026, payment by March 4, 2026.

Likely market impact

Strong revenue growth and generous dividend with special component reward shareholders, but YoY profit decline may limit upside.